Shanghai Synthetic Biology Innovation Center

The Shanghai Synthetic Biology Innovation Center is a Shanghai-based institution focused on advancing synthetic biology research and its commercial translation, notably through a "virtual company" model that provides concept-validation support to early-stage projects rather than immediately pushing them toward formal incorporation . As of 2025 reporting, it had completed concept-validation support for 14 projects, drawing from a pipeline of over 500 frontier directions .

The center operates within Shanghai's broader push to build a globally influential bio-manufacturing innovation hub. It is a founding member of the "Bio-Manufacturing Industry Value Partners" joint council, alongside Dalton Venture, Novo Holdings, East China University of Science and Technology, Jiangnan University, OPM Biosciences, and Meihua Holdings Group—an alliance aimed at closing the "last mile" between laboratory results and production-line application . Its deputy director, Qi Yesi, has represented the center at industry conferences alongside senior figures from partner institutions .